JP2003519089A - 肺炎球菌表面型蛋白質配合ワクチン - Google Patents

肺炎球菌表面型蛋白質配合ワクチン

Info

Publication number
JP2003519089A
JP2003519089A JP2001502874A JP2001502874A JP2003519089A JP 2003519089 A JP2003519089 A JP 2003519089A JP 2001502874 A JP2001502874 A JP 2001502874A JP 2001502874 A JP2001502874 A JP 2001502874A JP 2003519089 A JP2003519089 A JP 2003519089A
Authority
JP
Japan
Prior art keywords
antigenic determinant
pspa
psaa
pspc
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003519089A5 (cg-RX-API-DMAC7.html
Inventor
ヒューブナー、ロバート、シー.
サンプソン、ジャクリン、エス.
カーロン、ジョージ、エム.
アデス、エドウィン
ブリレス、デビット、イー.
Original Assignee
ユーエイビー リサーチ ファウンデーション
アヴェンティス パスツール
センターズ フォー ディズィーズ コントロール アンド プレヴェンション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユーエイビー リサーチ ファウンデーション, アヴェンティス パスツール, センターズ フォー ディズィーズ コントロール アンド プレヴェンション filed Critical ユーエイビー リサーチ ファウンデーション
Publication of JP2003519089A publication Critical patent/JP2003519089A/ja
Publication of JP2003519089A5 publication Critical patent/JP2003519089A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2001502874A 1999-06-10 2000-06-09 肺炎球菌表面型蛋白質配合ワクチン Pending JP2003519089A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13842299P 1999-06-10 1999-06-10
US60/138,422 1999-06-10
US58783300A 2000-06-06 2000-06-06
US09/587,833 2000-06-06
PCT/US2000/040176 WO2000076541A1 (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Publications (2)

Publication Number Publication Date
JP2003519089A true JP2003519089A (ja) 2003-06-17
JP2003519089A5 JP2003519089A5 (cg-RX-API-DMAC7.html) 2005-11-17

Family

ID=26836182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502874A Pending JP2003519089A (ja) 1999-06-10 2000-06-09 肺炎球菌表面型蛋白質配合ワクチン

Country Status (7)

Country Link
EP (1) EP1189632A4 (cg-RX-API-DMAC7.html)
JP (1) JP2003519089A (cg-RX-API-DMAC7.html)
AU (1) AU6121000A (cg-RX-API-DMAC7.html)
BR (1) BR0011478A (cg-RX-API-DMAC7.html)
CA (1) CA2379327A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01012721A (cg-RX-API-DMAC7.html)
WO (1) WO2000076541A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150140509A (ko) * 2014-06-05 2015-12-16 한국생명공학연구원 PspA를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1477802A1 (en) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Method for selecting and producing vaccine components and vaccines based thereon
US20110002962A1 (en) * 2006-08-17 2011-01-06 The Uab Research Foundation Immunogenic PcpA Polypeptides and Uses Thereof
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
EP1060249A1 (en) * 1998-03-02 2000-12-20 The Government of the United States represented by the Secretary of the Department of Health and Human Services Epitope peptides immunogenic against streptococcus pneumoniae
WO1999053940A1 (en) * 1998-04-23 1999-10-28 Uab Research Foundation PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150140509A (ko) * 2014-06-05 2015-12-16 한국생명공학연구원 PspA를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물
KR101627285B1 (ko) 2014-06-05 2016-06-07 한국생명공학연구원 PspA를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Also Published As

Publication number Publication date
EP1189632A4 (en) 2002-08-21
BR0011478A (pt) 2002-03-19
EP1189632A1 (en) 2002-03-27
CA2379327A1 (en) 2000-12-21
MXPA01012721A (es) 2004-10-14
AU6121000A (en) 2001-01-02
WO2000076541A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
FI118591B (fi) Immunologiset yhdistelmäkoostumukset ja niiden käyttö
ES2251124T3 (es) Vacuna que comprende un antigeno de streptococcus pneumoniae adyuvado por un oligonucleotido cpg.
ES2284285T3 (es) Adyuvante que contiene peptidos n-formilmetionilicos para vacunas.
ES2659400T3 (es) Vacuna contra Streptococcus pneumoniae
US8182821B2 (en) Flu vaccine admixture of mannan and flu antigen
NZ537120A (en) Compositions and methods for transepithelial molecular transport
JP2001510169A (ja) B型髄膜炎菌性ポーリンおよびH.influenzae多糖体を含む免疫原性結合体
JP2000503676A (ja) 肺炎球菌表面タンパク質の菌株選択及び関連する応用
US20230015616A1 (en) Coronavirus vaccines and uses thereof
PT1320542E (pt) Ácidos nucleicos de estreptococo de grupo b, polipéptidos, composições terapêuticas e vacinas correspondentes
AU2012277893A1 (en) Canine coronavirus vaccine
ES2334185T3 (es) Proteina psaa lipidada recombinante, procedimientos de preparacion y uilizacion.
Bastien et al. Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines
US20050260225A1 (en) Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
CN102488898B (zh) 龋齿疫苗及制备方法
JPH0840927A (ja) 肺炎球菌抗原の経粘膜投与方法
CN109069424A (zh) 脂质体疫苗
AU6121000A (en) Pneumococcal surface protein combination vaccine
US7255867B2 (en) Vaccine
TWI871759B (zh) 豬流行性下痢病毒之dna疫苗及其應用
JP2003525208A (ja) 肺炎連鎖球菌感染症に対する抗体に基づく治療
WO2026038177A1 (en) Immunogenic compositions and uses thereof
Schoolnik Molecular concepts of bacterial pathogenesis
HK1139155A (en) Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040427

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070510

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070514